Clinical Trials Browser

Phase 2 × Icrucumab × Breast × Clear all

NCT01234402 2019-08-14

Study of Icrucumab (IMC-18F1) or Ramucirumab Drug Product (DP) in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer Patients

Phase 2 Completed

153 enrolled 22 charts

Breast Neoplasms